Cyanide

Cyanide

SCHEMBL25405038

C#N.C#N.NN=Cc1ccc2[nH]c(=O)ccc2c1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 2/20 0.46
▸ CA9 Q16790 2/20 0.46
▸ F11 P03951 1/20 0.46
▸ PDE3B Q13370 2/20 0.44
▸ PDE3A Q14432 2/20 0.44
▸ TBXAS1 P24557 1/20 0.44
▸ CA1 P00915 1/20 0.40
▸ CA3 P07451 1/20 0.40
▸ CA4 P22748 1/20 0.40
▸ CA6 P23280 1/20 0.40
▸ CA5A P35218 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA13 Q8N1Q1 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ CA5B Q9Y2D0 1/20 0.40
▸ AR P10275 1/20 0.38
▸ MAPT P10636 4/20 0.36
▸ PKM P14618 1/20 0.36
▸ IDO1 P14902 1/20 0.36
▸ MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyanide SCHEMBL22130248 0.76 GRIN2D (0.57) CA12CA9CA1MAPTGRIN2D
Cyanide SCHEMBL22130260 0.76 GAA (0.41) PDE3BPDE3AMAPTPKMMEN1
SCHEMBL5049996 0.75 CYP2A6 (0.56) CA12CA9F11PDE3BPDE3A
SCHEMBL9411128 0.74 CA12 (0.59) CA12CA9F11PDE3BPDE3A
Cyanide SCHEMBL22130083 0.73 PDE3B (0.43) PDE3BPDE3AMAPTPKMPOLB
Cyanide SCHEMBL22130088 0.72 NOS1 (0.47) PDE3BPDE3AMAPTMEN1KMT2A
Cyanide SCHEMBL22130314 0.71 MAOB (0.53) MAPTMEN1KMT2AMAPK1POLB
SCHEMBL10838109 0.69 PDE3B (0.49) CA12CA9F11PDE3BPDE3A
Cyanide SCHEMBL25407293 0.69 PARP1 (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL10838112 0.69 PDE3B (0.49) CA12CA9F11PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US claimed
EP-4169905-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 — — EP claimed
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US disclosed
EP-4169905-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF CBR3, DBF4, DDT CA12 274/4885CA9 298/4885F11 2413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback